{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:16:00Z","timestamp":1793924160612,"version":"4.8.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Aging"],"DOI":"10.1038\/s43587-026-01143-w","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T09:02:49Z","timestamp":1784019769000},"page":"1468-1481","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Spatiotemporal dynamics of tau extent and load increase in Alzheimer\u2019s disease across four longitudinal cohorts"],"prefix":"10.1038","volume":"6","author":[{"given":"Arthur C.","family":"Macedo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5593-7717","authenticated-orcid":false,"given":"Lydia","family":"Trudel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Therriault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesrine","family":"Rahmouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9tienne","family":"Aumont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gleb","family":"Bezgin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7542-7541","authenticated-orcid":false,"given":"Seyyed Ali","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Tissot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9134-5949","authenticated-orcid":false,"given":"Tevy","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stijn","family":"Servaes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4578-2033","authenticated-orcid":false,"given":"Brandon","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9130-5461","authenticated-orcid":false,"given":"Yi-Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kely","family":"Quispialaya-Socualaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1306-2708","authenticated-orcid":false,"given":"Marcel S.","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Fernandez-Arias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna","family":"Stevenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yansheng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina Pereira","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firoza Z.","family":"Lussier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2183-1551","authenticated-orcid":false,"given":"Jo\u00e3o Pedro","family":"Ferrari-Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2134-9829","authenticated-orcid":false,"given":"Pamela C. L.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna","family":"Bellaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme","family":"Povala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4488-763X","authenticated-orcid":false,"given":"Livia Silva do","family":"Amaral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gassan","family":"Massarweh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Soucy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin L.","family":"Meeker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith N.","family":"Braskie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8856-1352","authenticated-orcid":false,"given":"Tobey J.","family":"Betthauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9653-559X","authenticated-orcid":false,"given":"Bradley T.","family":"Christian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramiro Eduardo","family":"Rea Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica K.","family":"Caldwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3579-8804","authenticated-orcid":false,"given":"Nicholas J.","family":"Ashton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1422-4358","authenticated-orcid":false,"given":"Thomas K.","family":"Karikari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3930-4354","authenticated-orcid":false,"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1890-4193","authenticated-orcid":false,"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5349-0053","authenticated-orcid":false,"given":"Eduardo R.","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9a L.","family":"Benedet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8501-545X","authenticated-orcid":false,"given":"Sterling C.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9057-8014","authenticated-orcid":false,"given":"Tharick A.","family":"Pascoal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9116-1376","authenticated-orcid":false,"given":"Pedro","family":"Rosa-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Alzheimer\u2019s Disease Neuroimaging Initiative","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,14]]},"reference":[{"key":"1143_CR1","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak, H. & Braak, E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82, 239\u2013259 (1991).","journal-title":"Acta Neuropathol."},{"key":"1143_CR2","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","volume":"112","author":"H Braak","year":"2006","unstructured":"Braak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H. & Del Tredici, K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol. 112, 389\u2013404 (2006).","journal-title":"Acta Neuropathol."},{"key":"1143_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","volume":"8","author":"BT Hyman","year":"2012","unstructured":"Hyman, B. T. et al. National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease. Alzheimers Dement. 8, 1\u201313 (2012).","journal-title":"Alzheimers Dement."},{"key":"1143_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","volume":"123","author":"TJ Montine","year":"2012","unstructured":"Montine, T. J. et al. National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: a practical approach. Acta Neuropathol. 123, 1\u201311 (2012).","journal-title":"Acta Neuropathol."},{"key":"1143_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105080","volume":"103","author":"S Doering","year":"2024","unstructured":"Doering, S. et al. Deconstructing pathological tau by biological process in early stages of Alzheimer disease: a method for quantifying tau spatial spread in neuroimaging. EBioMedicine 103, 105080 (2024).","journal-title":"EBioMedicine"},{"key":"1143_CR6","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1007\/s00259-024-06603-2","volume":"51","author":"T G\u00e9rard","year":"2024","unstructured":"G\u00e9rard, T. et al. The spatial extent of tauopathy on [18F]MK-6240 tau PET shows stronger association with cognitive performances than the standard uptake value ratio in Alzheimer\u2019s disease. Eur. J. Nucl. Med. Mol. Imaging 51, 1662\u20131674 (2024).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"1143_CR7","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcae031","volume":"6","author":"F St-Onge","year":"2024","unstructured":"St-Onge, F., Chapleau, M., Breitner, J. C. S., Villeneuve, S. & Pichet Binette, A. Tau accumulation and its spatial progression across the Alzheimer\u2019s disease spectrum. Brain Commun. 6, fcae031 (2024).","journal-title":"Brain Commun."},{"key":"1143_CR8","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abh1448","volume":"7","author":"G Meisl","year":"2021","unstructured":"Meisl, G. et al. In vivo rate-determining steps of tau seed accumulation in Alzheimer\u2019s disease. Sci. Adv. 7, eabh1448 (2021).","journal-title":"Sci. Adv."},{"key":"1143_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00401-023-02574-0","volume":"146","author":"M Manca","year":"2023","unstructured":"Manca, M. et al. Tau seeds occur before earliest Alzheimer\u2019s changes and are prevalent across neurodegenerative diseases. Acta Neuropathol. 146, 31\u201350 (2023).","journal-title":"Acta Neuropathol."},{"key":"1143_CR10","doi-asserted-by":"publisher","first-page":"7709","DOI":"10.1523\/JNEUROSCI.2177-05.2005","volume":"25","author":"RL Buckner","year":"2005","unstructured":"Buckner, R. L. et al. Molecular, structural, and functional characterization of Alzheimer\u2019s disease: evidence for a relationship between default activity, amyloid, and memory. J. Neurosci. 25, 7709\u20137717 (2005).","journal-title":"J. Neurosci."},{"key":"1143_CR11","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abd1327","volume":"6","author":"N Franzmeier","year":"2020","unstructured":"Franzmeier, N. et al. Patient-centered connectivity-based prediction of tau pathology spread in Alzheimer\u2019s disease. Sci. Adv. 6, eabd1327 (2020).","journal-title":"Sci. Adv."},{"key":"1143_CR12","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abc8693","volume":"14","author":"J Therriault","year":"2022","unstructured":"Therriault, J. et al. Intrinsic connectivity of the human brain provides scaffold for tau aggregation in clinical variants of Alzheimer\u2019s disease. Sci. Transl. Med. 14, eabc8693 (2022).","journal-title":"Sci. Transl. Med."},{"key":"1143_CR13","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","volume":"12","author":"CR Jack Jr","year":"2013","unstructured":"Jack, C. R. Jr et al. Tracking pathophysiological processes in Alzheimer\u2019s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 12, 207\u2013216 (2013).","journal-title":"Lancet Neurol."},{"key":"1143_CR14","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aau5732","volume":"12","author":"R La Joie","year":"2020","unstructured":"La Joie, R. et al. Prospective longitudinal atrophy in Alzheimer\u2019s disease correlates with the intensity and topography of baseline tau-PET. Sci. Transl. Med. 12, eaau5732 (2020).","journal-title":"Sci. Transl. Med."},{"key":"1143_CR15","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.2967\/jnumed.122.265200","volume":"64","author":"AC Macedo","year":"2023","unstructured":"Macedo, A. C. et al. The use of tau PET to stage Alzheimer disease according to the Braak staging framework. J. Nucl. Med. 64, 1171\u20131178 (2023).","journal-title":"J. Nucl. Med."},{"key":"1143_CR16","doi-asserted-by":"publisher","first-page":"414","DOI":"10.14283\/jpad.2024.15","volume":"11","author":"AC Macedo","year":"2024","unstructured":"Macedo, A. C. et al. Clinical correlates of the PET-based Braak staging framework in Alzheimer\u2019s disease. J. Prev. Alzheimers Dis. 11, 414\u2013421 (2024).","journal-title":"J. Prev. Alzheimers Dis."},{"key":"1143_CR17","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000214111","volume":"105","author":"L Trudel","year":"2025","unstructured":"Trudel, L. et al. Implication for clinical trials from longitudinal tau-PET accumulation across biological Alzheimer disease stages. Neurology 105, e214111 (2025).","journal-title":"Neurology"},{"key":"1143_CR18","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1001\/jamaneurol.2023.3599","volume":"80","author":"ME Belloy","year":"2023","unstructured":"Belloy, M. E. et al. APOE genotype and Alzheimer disease risk across age, sex, and population ancestry. JAMA Neurol. 80, 1284\u20131294 (2023).","journal-title":"JAMA Neurol."},{"key":"1143_CR19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40478-020-0884-2","volume":"8","author":"M Roberts","year":"2020","unstructured":"Roberts, M. et al. Pre-clinical characterization of E2814, a high-affinity antibody targeting the microtubule-binding repeat domain of tau for passive immunotherapy in Alzheimer\u2019s disease. Acta Neuropathol. Commun. 8, 13 (2020).","journal-title":"Acta Neuropathol. Commun."},{"key":"1143_CR20","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s00401-023-02659-w","volume":"147","author":"J Lantero-Rodriguez","year":"2024","unstructured":"Lantero-Rodriguez, J. et al. CSF p-tau205: a biomarker of tau pathology in Alzheimer\u2019s disease. Acta Neuropathol. 147, 12 (2024).","journal-title":"Acta Neuropathol."},{"key":"1143_CR21","doi-asserted-by":"publisher","first-page":"5343","DOI":"10.1002\/alz.13119","volume":"19","author":"J Lantero-Rodriguez","year":"2023","unstructured":"Lantero-Rodriguez, J. et al. Plasma and CSF concentrations of N-terminal tau fragments associate with in vivo neurofibrillary tangle burden. Alzheimers Dement. 19, 5343\u20135354 (2023).","journal-title":"Alzheimers Dement."},{"key":"1143_CR22","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1038\/s41591-023-02443-z","volume":"29","author":"K Horie","year":"2023","unstructured":"Horie, K. et al. CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer\u2019s disease. Nat. Med. 29, 1954\u20131963 (2023).","journal-title":"Nat. Med."},{"key":"1143_CR23","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1002\/alz.13528","volume":"20","author":"MS Woo","year":"2024","unstructured":"Woo, M. S. et al. Plasma pTau-217 and N-terminal tau (NTA) enhance sensitivity to identify tau PET positivity in amyloid-\u03b2 positive individuals. Alzheimers Dement. 20, 1166\u20131174 (2024).","journal-title":"Alzheimers Dement."},{"key":"1143_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105413","volume":"109","author":"MS Woo","year":"2024","unstructured":"Woo, M. S. et al. Identification of late-stage tau accumulation using plasma phospho-tau217. EBioMedicine 109, 105413 (2024).","journal-title":"EBioMedicine"},{"key":"1143_CR25","doi-asserted-by":"publisher","first-page":"4463","DOI":"10.1002\/alz.13393","volume":"19","author":"PCL Ferreira","year":"2023","unstructured":"Ferreira, P. C. L. et al. Plasma p-tau231 and p-tau217 inform on tau tangles aggregation in cognitively impaired individuals. Alzheimers Dement. 19, 4463\u20134474 (2023).","journal-title":"Alzheimers Dement."},{"key":"1143_CR26","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2967\/jnumed.124.267539","volume":"66","author":"A Aliaga","year":"2025","unstructured":"Aliaga, A. et al. Comparison between brain and cerebellar autoradiography using [18F]flortaucipir, [18F]MK6240, and [18F]PI2620 in postmortem human brain tissue. J. Nucl. Med. 66, 123\u2013129 (2025).","journal-title":"J. Nucl. Med."},{"key":"1143_CR27","first-page":"130","volume":"10","author":"SC Johnson","year":"2017","unstructured":"Johnson, S. C. et al. The Wisconsin Registry for Alzheimer\u2019s Prevention: a review of findings and current directions. Alzheimers Dement. 10, 130\u2013142 (2017).","journal-title":"Alzheimers Dement."},{"key":"1143_CR28","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1001\/jamaneurol.2019.4421","volume":"77","author":"J Therriault","year":"2020","unstructured":"Therriault, J. et al. Association of apolipoprotein E \u03f54 with medial temporal tau independent of amyloid-\u03b2. JAMA Neurol. 77, 470\u2013479 (2020).","journal-title":"JAMA Neurol."},{"key":"1143_CR29","volume":"11","author":"ME Petersen","year":"2025","unstructured":"Petersen, M. E. et al. Health and Aging Brain Study-Health Disparities (HABS-HD) methods and partner characteristics. Alzheimers Dement. 11, e70140 (2025).","journal-title":"Alzheimers Dement."},{"key":"1143_CR30","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1212\/WNL.0b013e3181cb3e25","volume":"74","author":"RC Petersen","year":"2010","unstructured":"Petersen, R. C. et al. Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI): clinical characterization. Neurology 74, 201\u2013209 (2010).","journal-title":"Neurology"},{"key":"1143_CR31","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1093\/brain\/awy059","volume":"141","author":"CR Jack Jr","year":"2018","unstructured":"Jack, C. R. Jr et al. Longitudinal tau PET in ageing and Alzheimer\u2019s disease. Brain 141, 1517\u20131528 (2018).","journal-title":"Brain"},{"key":"1143_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/alz.094383","volume":"20","author":"G Povala","year":"2025","unstructured":"Povala, G. et al. Universal tau PET scale (Uni\u03c4)\u2014The HEAD Study. Alzheimers Dement. 20, e094383 (2025).","journal-title":"Alzheimers Dement."},{"key":"1143_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14470","volume":"21","author":"Q Huang","year":"2025","unstructured":"Huang, Q. et al. Performance of study partner reports in a non-demented at-risk sample. Alzheimers Dement. 21, e14470 (2025).","journal-title":"Alzheimers Dement."},{"key":"1143_CR34","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1001\/archneur.1991.00530150046016","volume":"48","author":"K Welsh","year":"1991","unstructured":"Welsh, K., Butters, N., Hughes, J., Mohs, R. & Heyman, A. Detection of abnormal memory decline in mild cases of Alzheimer\u2019s disease using CERAD neuropsychological measures. Arch. Neurol. 48, 278\u2013281 (1991).","journal-title":"Arch. Neurol."},{"key":"1143_CR35","first-page":"215","volume":"28","author":"A Rey","year":"1941","unstructured":"Rey, A. L\u2019examen psychologique dans les cas d\u2019enc\u00e9phalopathie traumatique (les problems.) [The psychological examination in cases of traumatic encepholopathy. Problems]. Arch. Psychol. 28, 215\u2013285 (1941).","journal-title":"Arch. Psychol."},{"key":"1143_CR36","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1076\/clin.16.4.439.13908","volume":"16","author":"HM Gonz\u00e1lez","year":"2002","unstructured":"Gonz\u00e1lez, H. M., Mungas, D. & Haan, M. N. A verbal learning and memory test for English- and Spanish-speaking older Mexican-American adults. Clin. Neuropsychol. 16, 439\u2013451 (2002).","journal-title":"Clin. Neuropsychol."},{"key":"1143_CR37","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13195-019-0550-8","volume":"11","author":"MJ Leit\u00e3o","year":"2019","unstructured":"Leit\u00e3o, M. J. et al. Clinical validation of the Lumipulse G cerebrospinal fluid assays for routine diagnosis of Alzheimer\u2019s disease. Alzheimers Res. Ther. 11, 91 (2019).","journal-title":"Alzheimers Res. Ther."},{"key":"1143_CR38","doi-asserted-by":"publisher","first-page":"247","DOI":"10.2967\/jnumed.120.245209","volume":"62","author":"J Therriault","year":"2021","unstructured":"Therriault, J. et al. Determining amyloid-\u03b2 positivity using 18F-AZD4694 PET imaging. J. Nucl. Med. 62, 247\u2013252 (2021).","journal-title":"J. Nucl. Med."},{"key":"1143_CR39","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1001\/jamaneurol.2022.4485","volume":"80","author":"J Therriault","year":"2023","unstructured":"Therriault, J. et al. Association of phosphorylated tau biomarkers with amyloid positron emission tomography vs tau positron emission tomography. JAMA Neurol. 80, 188\u2013199 (2023).","journal-title":"JAMA Neurol."},{"key":"1143_CR40","doi-asserted-by":"publisher","first-page":"e47905","DOI":"10.1371\/journal.pone.0047905","volume":"7","author":"L Wu","year":"2012","unstructured":"Wu, L. et al. Dissociation between brain amyloid deposition and metabolism in early mild cognitive impairment. PLoS ONE 7, e47905 (2012).","journal-title":"PLoS ONE"},{"key":"1143_CR41","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1093\/brain\/awaa180","volume":"143","author":"TA Pascoal","year":"2020","unstructured":"Pascoal, T. A. et al. 18F-MK-6240 PET for early and late detection of neurofibrillary tangles. Brain 143, 2818\u20132830 (2020).","journal-title":"Brain"},{"key":"1143_CR42","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.neurobiolaging.2024.09.009","volume":"144","author":"AC Macedo","year":"2024","unstructured":"Macedo, A. C. et al. Modeling the progression of neuropsychiatric symptoms in Alzheimer\u2019s disease with PET-based Braak staging. Neurobiol. Aging 144, 127\u2013137 (2024).","journal-title":"Neurobiol. Aging"},{"key":"1143_CR43","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcae043","volume":"6","author":"AC Macedo","year":"2024","unstructured":"Macedo, A. C. et al. Predicting functional decline in aging and Alzheimer\u2019s disease with PET-based Braak staging. Brain Commun. 6, fcae043 (2024).","journal-title":"Brain Commun."},{"key":"1143_CR44","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s43587-022-00204-0","volume":"2","author":"J Therriault","year":"2022","unstructured":"Therriault, J. et al. Biomarker modeling of Alzheimer\u2019s disease using PET-based Braak staging. Nat. Aging 2, 526\u2013535 (2022).","journal-title":"Nat. Aging"},{"key":"1143_CR45","doi-asserted-by":"publisher","first-page":"4065","DOI":"10.1093\/brain\/awac213","volume":"145","author":"TJ Betthauser","year":"2022","unstructured":"Betthauser, T. J. et al. Multi-method investigation of factors influencing amyloid onset and impairment in three cohorts. Brain 145, 4065\u20134079 (2022).","journal-title":"Brain"},{"key":"1143_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14406","volume":"21","author":"RE Rea Reyes","year":"2025","unstructured":"Rea Reyes, R. E. et al. Visual read of [F-18]florquinitau PET that includes and extends beyond the mesial temporal lobe is associated with increased plasma pTau217 and cognitive decline in a cohort that is enriched with risk for Alzheimer\u2019s disease. Alzheimers Dement. 21, e14406 (2025).","journal-title":"Alzheimers Dement."},{"key":"1143_CR47","doi-asserted-by":"publisher","DOI":"10.1162\/IMAG.a.41","volume":"16","author":"VR Tennant","year":"2025","unstructured":"Tennant, V. R. et al. Establishing tau-PET cut-points for cognitive diagnosis with 18 F-PI-2620 in a multi-ethnoracial cohort. Imaging Neurosci. 16, IMAG.a.41 (2025).","journal-title":"Imaging Neurosci."},{"key":"1143_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52265-x","volume":"15","author":"P Kunach","year":"2024","unstructured":"Kunach, P. et al. Cryo-EM structure of Alzheimer\u2019s disease tau filaments with PET ligand MK-6240. Nat. Commun. 15, 8497 (2024).","journal-title":"Nat. Commun."},{"key":"1143_CR49","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1002\/ana.24517","volume":"78","author":"M Marqui\u00e9","year":"2015","unstructured":"Marqui\u00e9, M. et al. Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue. Ann. Neurol. 78, 787\u2013800 (2015).","journal-title":"Ann. Neurol."},{"key":"1143_CR50","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","volume":"20","author":"CR Jack Jr","year":"2024","unstructured":"Jack, C. R. Jr et al. Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup. Alzheimers Dement. 20, 5143\u20135169 (2024).","journal-title":"Alzheimers Dement."},{"key":"1143_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2025.11.002","volume":"158","author":"E Aumont","year":"2026","unstructured":"Aumont, E. et al. Optimized atlas for early tau-PET staging via native space segmentations. Neurobiol. Aging 158, 1\u201310 (2026).","journal-title":"Neurobiol. Aging"},{"key":"1143_CR52","doi-asserted-by":"publisher","first-page":"452","DOI":"10.2967\/jnumed.122.264434","volume":"64","author":"C Tissot","year":"2023","unstructured":"Tissot, C. et al. The association of age-related and off-target retention with longitudinal quantification of [18F]MK6240 tau PET in target regions. J. Nucl. Med. 64, 452\u2013459 (2023).","journal-title":"J. Nucl. Med."},{"key":"1143_CR53","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jalz.2016.08.005","volume":"13","author":"CR Jack Jr","year":"2017","unstructured":"Jack, C. R. Jr et al. Defining imaging biomarker cut points for brain aging and Alzheimer\u2019s disease. Alzheimers Dement 13, 205\u2013216 (2017).","journal-title":"Alzheimers Dement"},{"key":"1143_CR54","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14378","volume":"21","author":"SM Landau","year":"2025","unstructured":"Landau, S. M. et al. Positron emission tomography harmonization in the Alzheimer\u2019s Disease Neuroimaging Initiative: a scalable and rigorous approach to multisite amyloid and tau quantification. Alzheimers Dement. 21, e14378 (2025).","journal-title":"Alzheimers Dement."},{"key":"1143_CR55","doi-asserted-by":"publisher","first-page":"e68910","DOI":"10.1371\/journal.pone.0068910","volume":"8","author":"M Xia","year":"2013","unstructured":"Xia, M., Wang, J. & He, Y. BrainNet Viewer: a network visualization tool for human brain connectomics. PLoS ONE 8, e68910 (2013).","journal-title":"PLoS ONE"},{"key":"1143_CR56","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1093\/brain\/awad397","volume":"147","author":"Y-T Wang","year":"2024","unstructured":"Wang, Y.-T. et al. Sex-specific modulation of amyloid-\u03b2 on tau phosphorylation underlies faster tangle accumulation in females. Brain 147, 1497\u20131510 (2024).","journal-title":"Brain"},{"key":"1143_CR57","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1038\/s43587-023-00490-2","volume":"3","author":"JP Ferrari-Souza","year":"2023","unstructured":"Ferrari-Souza, J. P. et al. APOE\u03b54 potentiates amyloid \u03b2 effects on longitudinal tau pathology. Nat. Aging 3, 1210\u20131218 (2023).","journal-title":"Nat. Aging"},{"key":"1143_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-022-00590-4","volume":"18","author":"CB Young","year":"2023","unstructured":"Young, C. B. et al. APOE effects on regional tau in preclinical Alzheimer\u2019s disease. Mol. Neurodegener. 18, 1 (2023).","journal-title":"Mol. Neurodegener."},{"key":"1143_CR59","doi-asserted-by":"publisher","first-page":"e0121945","DOI":"10.1371\/journal.pone.0121945","volume":"10","author":"B Diedenhofen","year":"2015","unstructured":"Diedenhofen, B. et al. cocor: a comprehensive solution for the statistical comparison of correlations. PLoS ONE 10, e0121945 (2015).","journal-title":"PLoS ONE"}],"container-title":["Nature Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43587-026-01143-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43587-026-01143-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43587-026-01143-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T13:02:32Z","timestamp":1784206952000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43587-026-01143-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":59,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["1143"],"URL":"https:\/\/doi.org\/10.1038\/s43587-026-01143-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5619837\/v1","asserted-by":"object"}]},"ISSN":["2662-8465"],"issn-type":[{"value":"2662-8465","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,14]]},"assertion":[{"value":"15 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.T. has served as a consultant for the Neurotorium educational platform, outside the scope of the submitted work. N.J.A. has received consulting fees from Quanterix and has also received payments for lectures, presentations, speakers\u2019 bureaus, manuscript writing or educational events from Alamar Biosciences, Biogen, Eli Lilly and Quanterix. N.J.A. is listed as an inventor on a patent application no. PCT\/US2024\/037834 (WSGRDocket no. 58484-709.601) related to methods for remote blood collection, extraction and analysis of neuro biomarkers; serves on the advisory board for Biogen, TargetALS and TauRx; and receives payments for this role. T.K.K. has consulted for Quanterix, has received honoraria from the NIH for study section membership, and honoraria for speaker\/grant review engagements from the University of Pennsylvania, University of Wisconsin-Madison, Advent Health, the Brain Health conference, the Barcelona\u2013Pittsburgh conference and the Quebec Consortium for Drug Discovery Canada, all outside the submitted work. T.K.K. has received blood biomarker data on defined research cohorts from Janssen and Alamar Biosciences for independent analysis and publication, with no financial incentive or research funding included. T.K.K. is an inventor on patent no. WO2020193500A1 and patent applications nos. 2450702-2, 63\/693,956, 63\/679,361 and 63\/672,952. H.Z. has served at scientific advisory boards or as a consultant for Abbvie, Acumen, Alector, Alzinova, ALZpath, Amylyx, Annexon, Apellis, Artery Therapeutics, AZTherapies, Cognito Therapeutics, CogRx, Denali, Eisai, LabCorp, Merry Life, Nervgen, Novo Nordisk, Optoceutics, Passage Bio, Pinteon Therapeutics, Prothena, Quanterix, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics and Wave; has given lectures sponsored by Alzecure, BioArctic, Biogen, Cellectricon, Fujirebio, Eli Lilly, Novo Nordisk, Roche and WebMD; and is a co-founder of Brain Biomarker Solutions, which is a part of the GU Ventures Incubator Program (outside the submitted work). K.B. has served as a consultant and at advisory boards for Abbvie, AC Immune, ALZPath, AriBio, Beckman Coulter, BioArctic, Biogen, Eisai, Eli Lilly, Moleac, Neurimmune, Novartis, Ono Pharma, Prothena, Quanterix, Roche Diagnostics, Sanofi and Siemens Healthineers; has served at data monitoring committees for Julius Clinical and Novartis; has given lectures, produced educational materials and participated in educational programs for AC Immune, Biogen, Celdara Medical, Eisai and Roche Diagnostics; and is a co-founder of Brain Biomarker Solutions, which is a part of the GU Ventures Incubator Program, outside the work presented in this manuscript. E.R.Z. has served on scientific advisory boards for Nintx, Novo Nordisk and Masima. E.R.Z. is also a co-founder and a minority shareholder at Masima. P.R.-N. provides consultancy services for Roche, Cerveau Radiopharmaceuticals, Eli Lilly, Eisai, Pfizer and Novo Nordisk. P.R.-N. also serves as a clinical trial investigator for Biogen, Novo Nordisk and Biogen. M.S.W. received honoraria from Lilly and Eisai for lectures outside the scope of this paper. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}